Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ANAC

Arctos NorthStar Acquisition (ANAC) Stock Price, News & Analysis

Arctos NorthStar Acquisition logo

About Arctos NorthStar Acquisition Stock (NASDAQ:ANAC)

Advanced Chart

Key Stats

Today's Range
$10.19
$10.19
50-Day Range
$9.68
$9.79
52-Week Range
$9.44
$10.20
Volume
705 shs
Average Volume
53,611 shs
Market Capitalization
$402.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Arctos NorthStar Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It focuses on sports, media, and entertainment sectors. The company was founded in 2020 and is based in Dallas, Texas.

Receive ANAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arctos NorthStar Acquisition and its competitors with MarketBeat's FREE daily newsletter.

ANAC Stock News Headlines

Northstar Clean Technologies Inc ROOF
Metal Sky Star Acquisition Corp
Warning echoes from the Great Depression
This is an urgent warning for All American investors … The current economic chaos is just a preview … What's coming next could be way scarier. In fact, in a matter of days, we could see a radical shift in the stock market … Companies who've been flying high could come crashing to Earth.
Northstar California Resort
Arctos Northstar Acquisition Corp
See More Headlines

ANAC Stock Analysis - Frequently Asked Questions

Arctos NorthStar Acquisition Corp. (NASDAQ:ANAC) issued its earnings results on Tuesday, May, 10th. The biopharmaceutical company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by $0.01. The company's revenue was up 14.9% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arctos NorthStar Acquisition investors own include Portola Pharmaceuticals (PTLA), Micron Technology (MU), Bristol-Myers Squibb (BMY), bluebird bio (BLUE), Netflix (NFLX), Palo Alto Networks (PANW) and BioMarin Pharmaceutical (BMRN).

Company Calendar

Last Earnings
5/10/2016
Today
5/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & other investment offices
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ANAC
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$7.16 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.18 per share
Price / Cash Flow
56.23
Book Value
($0.63) per share
Price / Book
-16.17

Miscellaneous

Free Float
N/A
Market Cap
$402.81 million
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:ANAC) was last updated on 5/10/2025 by MarketBeat.com Staff
From Our Partners